Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.
- DOI
- 10.1016/j.annonc.2026.05.699
- Published
- 2026 Sep
- Container
- Annals of oncology : official journal of the European Society for Medical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2026.05.699,
title = {Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.},
author = {Pagani O and Niman SM and Ruggeri M and Peccatori FA and Azim HA Jr and Colleoni M and Saura C and Shimizu C and Sætersdal AB and Kroep JR and Warner E and Amant F and Mailliez A and Moore HCF and Ruiz-Borrego M and Walshe JM and Borges VF and Gombos A and Kataoka A and Rousset-Jablonski C and Borstnar S and Takei J and Lee JE and Saunders C and Bjelic-Radisic V and Susnjar S and Cardoso F and Klar NJ and Ferreiro T and Ribi K and Ruddy KJ and Kammler R and El-Abed S and Viale G and Piccart M and Korde LA and Goldhirsch A and Gelber RD and Partridge AH and International Breast Cancer Study Group and the POSITIVE Trial Consortium},
year = {2026},
journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
doi = {10.1016/j.annonc.2026.05.699},
url = {https://doi.org/10.1016/j.annonc.2026.05.699}
}RIS
TY - JOUR TI - Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial. AU - Pagani O AU - Niman SM AU - Ruggeri M AU - Peccatori FA AU - Azim HA Jr AU - Colleoni M AU - Saura C AU - Shimizu C AU - Sætersdal AB AU - Kroep JR AU - Warner E AU - Amant F AU - Mailliez A AU - Moore HCF AU - Ruiz-Borrego M AU - Walshe JM AU - Borges VF AU - Gombos A AU - Kataoka A AU - Rousset-Jablonski C AU - Borstnar S AU - Takei J AU - Lee JE AU - Saunders C AU - Bjelic-Radisic V AU - Susnjar S AU - Cardoso F AU - Klar NJ AU - Ferreiro T AU - Ribi K AU - Ruddy KJ AU - Kammler R AU - El-Abed S AU - Viale G AU - Piccart M AU - Korde LA AU - Goldhirsch A AU - Gelber RD AU - Partridge AH AU - International Breast Cancer Study Group and the POSITIVE Trial Consortium PY - 2026 JO - Annals of oncology : official journal of the European Society for Medical Oncology DO - 10.1016/j.annonc.2026.05.699 UR - https://doi.org/10.1016/j.annonc.2026.05.699 ER -
APA
O, P., SM, N., M, R., FA, P., Jr, A. H., M, C., C, S., C, S., AB, S., JR, K., E, W., F, A., A, M., HCF, M., M, R., JM, W., VF, B., A, G., A, K., C, R., S, B., J, T., JE, L., C, S., V, B., S, S., F, C., NJ, K., T, F., K, R., KJ, R., R, K., S, E., G, V., M, P., LA, K., A, G., RD, G., AH, P., & Consortium, I. B. C. S. G. A. T. P. T. (2026). Updated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.05.699
Source records
- pubmed · retrieved 2026-09-26T12:05:38.846Z